These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24269566)

  • 21. Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.
    Cesarini M; Katsanos K; Papamichael K; Ellul P; Lakatos PL; Caprioli F; Kopylov U; Tsianos E; Mantzaris GJ; Ben-Horin S; Danese S; Fiorino G
    Dig Liver Dis; 2014 Feb; 46(2):135-9. PubMed ID: 24246151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?
    Gearry RB; Irving PM
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1160-2. PubMed ID: 19682189
    [No Abstract]   [Full Text] [Related]  

  • 24. Etrolizumab for ulcerative colitis: the new kid on the block?
    Makker J; Hommes DW
    Expert Opin Biol Ther; 2016; 16(4):567-72. PubMed ID: 26914639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etrolizumab in moderate-to-severe ulcerative colitis.
    Armuzzi A; Felice C
    Lancet; 2014 Jul; 384(9940):285-6. PubMed ID: 24814088
    [No Abstract]   [Full Text] [Related]  

  • 26. Etrolizumab for ulcerative colitis: beyond what meets the eye.
    Agrawal M; Verstockt B
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):2-4. PubMed ID: 34798035
    [No Abstract]   [Full Text] [Related]  

  • 27. Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa.
    Fiorino G; Danese S
    Gastroenterology; 2014 Dec; 147(6):1433-5. PubMed ID: 25457851
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-tumor necrosis factor therapy for ulcerative colitis.
    Kountouras J; Zavos C; Chatzopoulos D
    Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
    Reinisch W; Sandborn WJ; Rutgeerts P; Feagan BG; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Blank M; Lang Y; Johanns J; Colombel JF; Present D; Sands BE
    Inflamm Bowel Dis; 2012 Feb; 18(2):201-11. PubMed ID: 21484965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis.
    Hyams J; Damaraju L; Blank M; Johanns J; Guzzo C; Winter HS; Kugathasan S; Cohen S; Markowitz J; Escher JC; Veereman-Wauters G; Crandall W; Baldassano R; Griffiths A;
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):391-9.e1. PubMed ID: 22155755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sucralfate enemas in ulcerative colitis.
    Winter TA; Marks IN
    Aliment Pharmacol Ther; 1997 Aug; 11(4):821-2. PubMed ID: 9305494
    [No Abstract]   [Full Text] [Related]  

  • 32. Ulcerative colitis: conservative management and long-term effects.
    Kühbacher T; Schreiber S; Fölsch UR
    Langenbecks Arch Surg; 2004 Oct; 389(5):350-3. PubMed ID: 15133672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Golimumab for moderately to severely active ulcerative colitis.
    Kedia S; Ahuja V; Makharia GK
    Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appendicectomy as a potential therapy for refractory ulcerative proctitis.
    Bageacu S; Coatmeur O; Lemaitre JP; Lointier P; Del Tedesco E; Phelip JM; Roblin X
    Aliment Pharmacol Ther; 2011 Jul; 34(2):257-8. PubMed ID: 21679209
    [No Abstract]   [Full Text] [Related]  

  • 35. Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?
    Christophi GP; Ciorba MA
    J Clin Gastroenterol; 2015 Aug; 49(7):539-40. PubMed ID: 26057322
    [No Abstract]   [Full Text] [Related]  

  • 36. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
    Halpin SJ; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450
    [No Abstract]   [Full Text] [Related]  

  • 37. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
    Reinisch W; Sandborn WJ; Hommes DW; D'Haens G; Hanauer S; Schreiber S; Panaccione R; Fedorak RN; Tighe MB; Huang B; Kampman W; Lazar A; Thakkar R
    Gut; 2011 Jun; 60(6):780-7. PubMed ID: 21209123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
    Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
    Aliment Pharmacol Ther; 2011 Feb; 33(3):412-3. PubMed ID: 21198699
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis.
    van Asseldonk DP; Jharap B; Kuik DJ; de Boer NK; Westerveld BD; Russel MG; Kubben FJ; van Bodegraven AA; Mulder CJ
    Dig Liver Dis; 2011 Feb; 43(2):110-5. PubMed ID: 20739231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided.
    Lopez-Sanroman A; Gisbert JP
    Aliment Pharmacol Ther; 2013 Oct; 38(8):992. PubMed ID: 24074311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.